GUCY2C and irritable bowel syndrome: Among the most notable examples have been drugs that activate the receptor/enzyme guanylyl cyclase C (GUCY2C), a product of the GUCY2C gene on intestinal mucosal cells and stimulate intestinal fluid secretion and motility to treat constipation-predominant IBS.